References
- Medeiros LJ, Greiner TC. Hodgkin’s disease. Cancer. 1995;75(S1):357–369. doi:10.1002/1097-0142(19950101)75:1.
- Cleary SF, Link MP, Donaldson SS. Hodgkin’s disease in the very young. Int J Radiat Oncol Biol Phys. 1994;28(1):77–83. doi: 10.1016/0360-3016(94)90143-0.
- Çavdar AO, Gözdaşoğlu S, Yavuz G, et al. Characteristics of "early type-I pattern" (0-6 years) Hodgkin’s disease in Turkish children. Turk J Haematol. 2002;19(1):55–62.
- Belgaumi A, Al-Kofide A, Joseph N, et al. Hodgkin lymphoma in very young children: clinical characteristics and outcome of treatment. Leuk Lymphoma. 2008;49(5):910–916. doi:10.1080/10428190801947492.
- Cartwright RA, Watkins G. Epidemiology of Hodgkin’s disease: a review. Hematol Oncol. 2004;22(1):11–26. doi:10.1002/hon.723.
- Kung FH. Hodgkin’s disease in children 4 years of age or younger. Cancer. 1991;67(5):1428–1430. doi:10.1002/1097-0142(19910301)67:5.
- Pourtsidis A, Doganis D, Baka M, et al. Differences between younger and older patients with childhood Hodgkin lymphoma. Pediatr Hematol Oncol. 2013;30(6):532–536. doi:10.3109/08880018.2013.823471.
- Farruggia P, Puccio G, Locatelli F, et al. Classical pediatric Hodgkin lymphoma in very young patients: the Italian experience. Leuk Lymphoma. 2019;60(3):696–702. doi:10.1080/10428194.2018.1493732.
- Karhan AN, Varan A, Akyüz C, et al. Outcome of 102 patients under 5 years of age with Hodgkin lymphoma. Arch Argent Pediatr. 2019;117(5):e459–e465. doi:10.5546/aap.2019.eng.e459.
- Stoneham S, Ashley S, Pinkerton R, et al. Hodgkin’s lymphoma in children aged 5 years or less - the United Kingdom experience. Eur J Cancer. 2007;43(9):1415–1421. doi:10.1016/j.ejca.2007.03.013.
- Englund A, Glimelius I, Rostgaard K, et al. Hodgkin lymphoma in children, adolescents and young adults - a comparative study of clinical presentation and treatment outcome. Acta Oncol. 2018;57(2):276–282. doi:10.1080/0284186X.2017.1355563.
- Marcotte EL, Ritz B, Cockburn M, et al. Birth characteristics and risk of lymphoma in young children. Cancer Epidemiol. 2014;38(1):48–55. doi:10.1016/j.canep.2013.11.005.
- Dupuis LL, Boodhan S, Sung L, et al. Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients. Pediatr Blood Cancer. 2011;57(2):191–198. doi:10.1002/pbc.23114.